TransMedics Group Inc
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
TMDX$93.79+6.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share amounts)
| March 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash | $350,217 | $394,812 |
| Accounts receivable | 81,942 | 63,576 |
| Inventory | 48,541 | 44,235 |
| Prepaid expenses and other current assets | 7,606 | 8,031 |
| Total current assets | 488,306 | 510,654 |
| Property, plant and equipment, net | 214,421 | 173,941 |
| Operating lease right-of-use assets | 6,226 | 6,546 |
| Restricted cash | 500 | 500 |
| Goodwill | 11,990 | 11,990 |
| Acquired intangible assets, net | 2,303 | 2,354 |
| Other non-current assets | 85 | 62 |
| Total assets | $723,831 | $706,047 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $9,225 | $12,717 |
| Accrued expenses and other current liabilities | 36,852 | 38,221 |
| Deferred revenue | 2,060 | 1,961 |
| Operating lease liabilities | 2,086 | 2,035 |
| Total current liabilities | 50,223 | 54,934 |
| Convertible senior notes, net | 447,835 | 447,140 |
| Long-term debt, net | 59,141 | 59,064 |
| Operating lease liabilities, net of current portion | 7,161 | 7,707 |
| Total liabilities | 564,360 | 568,845 |
| Commitments and contingencies (Note 11) | ||
| Stockholders' equity: | ||
| Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding | — | — |
| Common stock, no par value; 150,000,000 shares authorized; 32,851,376 shares and 32,670,803 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 651,161 | 641,106 |
| Accumulated other comprehensive loss | (182) | (199) |
| Accumulated deficit | (491,508) | (503,705) |
| Total stockholders' equity | 159,471 | 137,202 |
| Total liabilities and stockholders' equity | $723,831 | $706,047 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.